Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Altius Minerals Co. stock logo
ALS
Altius Minerals
C$21.92
+1.3%
C$19.74
C$16.11
C$22.40
C$1.03B0.9380,147 shs27,305 shs
Rio2 Limited stock logo
ATM
Rio2
C$0.68
+1.5%
C$0.68
C$0.57
C$0.86
C$57.62MN/A114,654 shs15,000 shs
BMN
Blackrock 2037 Municipal Target Term Trust
$23.92
+0.2%
$23.98
$21.51
$25.59
N/AN/A22,513 shs6,339 shs
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
C$0.26
-3.8%
C$0.26
C$0.15
C$0.53
C$52.28MN/A644,760 shs384,329 shs
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Altius Minerals Co. stock logo
ALS
Altius Minerals
+3.15%+0.75%+7.08%+20.77%-0.05%
Rio2 Limited stock logo
ATM
Rio2
0.00%0.00%0.00%0.00%0.00%
BMN
Blackrock 2037 Municipal Target Term Trust
-0.17%+0.08%-1.53%+2,386,999,900.00%+2,386,999,900.00%
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Altius Minerals Co. stock logo
ALS
Altius Minerals
0.7136 of 5 stars
1.40.00.80.01.72.51.3
Rio2 Limited stock logo
ATM
Rio2
N/AN/AN/AN/AN/AN/AN/AN/A
BMN
Blackrock 2037 Municipal Target Term Trust
N/AN/AN/AN/AN/AN/AN/AN/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Altius Minerals Co. stock logo
ALS
Altius Minerals
2.83
Moderate BuyC$22.713.62% Upside
Rio2 Limited stock logo
ATM
Rio2
N/AN/AN/AN/A
BMN
Blackrock 2037 Municipal Target Term Trust
N/AN/AN/AN/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/AN/AN/AN/A

Current Analyst Ratings

Latest ATM, BMN, EMH, and ALS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/22/2024
Altius Minerals Co. stock logo
ALS
Altius Minerals
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuyC$24.00 ➝ C$24.50
3/12/2024
Altius Minerals Co. stock logo
ALS
Altius Minerals
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ BuyC$22.00 ➝ C$23.00
2/6/2024
Altius Minerals Co. stock logo
ALS
Altius Minerals
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector PerformC$20.00 ➝ C$18.50
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Altius Minerals Co. stock logo
ALS
Altius Minerals
C$68.96M14.88C$2.03 per share10.80C$10.38 per share2.11
Rio2 Limited stock logo
ATM
Rio2
N/AN/AN/AN/AN/AN/A
BMN
Blackrock 2037 Municipal Target Term Trust
$11.91MN/AN/AN/AN/AN/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
C$13.02M4.02C$0.33 per share0.78C$0.40 per share0.64

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Altius Minerals Co. stock logo
ALS
Altius Minerals
C$9.54MC$0.20109.60N/A13.83%1.66%2.46%5/13/2024 (Estimated)
Rio2 Limited stock logo
ATM
Rio2
N/AN/A0.00N/AN/AN/AN/AN/A
BMN
Blackrock 2037 Municipal Target Term Trust
N/AN/A0.00N/AN/AN/AN/AN/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/A-C$0.70N/AN/AN/AN/AN/AN/A

Latest ATM, BMN, EMH, and ALS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/11/2024Q4 2023
Altius Minerals Co. stock logo
ALS
Altius Minerals
C$0.07C$0.06-C$0.01C$0.17C$18.85 millionC$16.10 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Altius Minerals Co. stock logo
ALS
Altius Minerals
C$0.321.46%N/A160.00%N/A
Rio2 Limited stock logo
ATM
Rio2
N/AN/AN/AN/AN/A
BMN
Blackrock 2037 Municipal Target Term Trust
$1.124.68%N/AN/A1 Years
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/AN/AN/AN/AN/A

Latest ATM, BMN, EMH, and ALS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/1/2024
BMN
Blackrock 2037 Municipal Target Term Trust
Monthly$0.09404.68%4/12/20244/15/20245/1/2024
3/11/2024
Altius Minerals Co. stock logo
ALS
Altius Minerals
QuarterlyC$0.081.56%3/15/20243/18/20244/1/2024
3/1/2024
BMN
Blackrock 2037 Municipal Target Term Trust
Monthly$0.09404.72%3/14/20243/15/20244/1/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Altius Minerals Co. stock logo
ALS
Altius Minerals
18.38
11.23
6.49
Rio2 Limited stock logo
ATM
Rio2
N/AN/AN/A
BMN
Blackrock 2037 Municipal Target Term Trust
N/AN/AN/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
35.45
2.97
2.61

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Altius Minerals Co. stock logo
ALS
Altius Minerals
1946.81 millionN/ANot Optionable
Rio2 Limited stock logo
ATM
Rio2
N/A84.74 millionN/ANot Optionable
BMN
Blackrock 2037 Municipal Target Term Trust
N/AN/AN/AN/A
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
161205.03 millionN/ANot Optionable

ATM, BMN, EMH, and ALS Headlines

SourceHeadline
University Hospitals Elyria Medical CenterUniversity Hospitals Elyria Medical Center
health.usnews.com - September 23 at 12:26 AM
Digital Therapeutics: Next wave in managing chronic medical conditionsDigital Therapeutics: Next wave in managing chronic medical conditions
health.economictimes.indiatimes.com - September 13 at 9:19 PM
The Digital Therapeutics Market Is GangbustersThe Digital Therapeutics Market Is Gangbusters
mddionline.com - August 29 at 11:45 PM
Digital Therapeutics (DTx) For Mental Health Market is Booming and Expected to Grow at a CAGR of 27.42% to 2031 | InsightAce StudyDigital Therapeutics (DTx) For Mental Health Market is Booming and Expected to Grow at a CAGR of 27.42% to 2031 | InsightAce Study
finance.yahoo.com - July 31 at 12:17 AM
Emerald Isle’s Lee Avenue to close again soon as culvert project restartsEmerald Isle’s Lee Avenue to close again soon as culvert project restarts
carolinacoastonline.com - July 15 at 8:44 AM
Efficient Market Hypothesis (EMH): Definition and CritiqueEfficient Market Hypothesis (EMH): Definition and Critique
investopedia.com - July 12 at 2:56 PM
Revolutionizing mental health treatment: Vistagen Therapeutics nasal spray solutionRevolutionizing mental health treatment: Vistagen Therapeutics' nasal spray solution
finance.yahoo.com - June 20 at 12:36 PM
Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023
thaipr.net - May 29 at 4:23 AM
Emerald Care Center TulsaEmerald Care Center Tulsa
health.usnews.com - May 4 at 11:26 PM
Emerald ReegEmerald Reeg
health.usnews.com - April 25 at 7:35 AM
Emerald Expositions GAAP EPS of $0.06, revenue of $93.6MEmerald Expositions GAAP EPS of $0.06, revenue of $93.6M
msn.com - March 14 at 9:07 AM
Tahoes Emerald Bay freezes over for first time in decades amid atmospheric riverTahoe's Emerald Bay freezes over for first time in decades amid atmospheric river
sfgate.com - March 13 at 4:02 AM
Visus Therapeutics to Attend TD Cowen’s 43rd Annual Health Care ConferenceVisus Therapeutics to Attend TD Cowen’s 43rd Annual Health Care Conference
venturebeat.com - March 4 at 6:25 PM
Emerald community raising money for local dialysis services after political campaigns failEmerald community raising money for local dialysis services after political campaigns fail
abc.net.au - February 25 at 12:07 AM
New Digital Therapeutics Company Takes a Swing at FibromyalgiaNew Digital Therapeutics Company Takes a 'Swing' at Fibromyalgia
mddionline.com - February 22 at 11:25 PM
Emerald Asset Management PA, LLC 30th Annual Emerald Groundhog Day Investment Forum Opens Amid a Stormy 2023 Investment YearEmerald Asset Management PA, LLC 30th Annual Emerald Groundhog Day Investment Forum Opens Amid a Stormy 2023 Investment Year
finance.yahoo.com - January 14 at 1:43 PM
Emerald Health Therapeutics Inc (TBD.BE)Emerald Health Therapeutics Inc (TBD.BE)
finance.yahoo.com - January 4 at 3:42 AM
Emerald Health Therapeutics Announces Revocation of Management Cease Trade OrderEmerald Health Therapeutics Announces Revocation of Management Cease Trade Order
finance.yahoo.com - July 12 at 9:36 AM
Emerald Health Therapeutics, Inc. Reports 2021 Year-End Results and Corporate UpdateEmerald Health Therapeutics, Inc. Reports 2021 Year-End Results and Corporate Update
finance.dailyherald.com - July 4 at 7:56 AM
Emerald Health Therapeutics Provides Bi-Weekly MCTO Status UpdateEmerald Health Therapeutics Provides Bi-Weekly MCTO Status Update
finance.yahoo.com - June 16 at 8:02 AM
Emerald Health Therapeutics, Inc. Provides Bi-Weekly MCTO Status UpdateEmerald Health Therapeutics, Inc. Provides Bi-Weekly MCTO Status Update
stockhouse.com - May 16 at 4:37 PM
Skye Bioscience Signs Arrangement Agreement with Emerald Health TherapeuticsSkye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics
nz.finance.yahoo.com - May 12 at 9:26 AM
Cannabis Stock News: Emerald Health Therapeutics, Inc. (CSE: EMH) Transfers US Listing to OTCQBCannabis Stock News: Emerald Health Therapeutics, Inc. (CSE: EMH) Transfers US Listing to OTCQB
investorideas.com - May 6 at 10:47 AM
Emperor Oil Ltd (EMh)Emperor Oil Ltd (EMh)
investing.com - January 5 at 8:00 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Altius Minerals logo

Altius Minerals

TSE:ALS
Altius Minerals Corporation operates as a diversified mining royalty and streaming company in Canada, the United States, and Brazil. The company owns royalty and streaming interests in 11 operating mines covering copper, zinc, nickel, cobalt, potash, iron ore, precious metals, and thermal and metallurgical coal. It is involved in the acquisition and management of renewable energy investments and royalties, as well as early-stage royalties and minority equity or project interests. Altius Minerals Corporation was incorporated in 1997 and is headquartered in St. John's, Canada.
Rio2 logo

Rio2

CVE:ATM
Atacama Pacific Gold Corporation, an exploration stage company, engages in the acquisition, exploration, and development of gold properties in Chile. The company principally holds a 100% interest in the Cerro Maricunga gold project located in Region III northeast of the city of Copiapo. Atacama Pacific Gold Corporation was incorporated in 2008 and is headquartered in Toronto, Canada.

Blackrock 2037 Municipal Target Term Trust

NYSE:BMN
Blackrock 2037 Municipal Target Term Trust is an close-ended fixed income mutual fund launched by Blackrock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in fixed income markets. The fund primarily invests in n investment grade municipal securities that are rated BBB- or above by S&P and Fitch or Baa3 or above by Moody's. Blackrock 2037 Municipal Target Term Trust is domiciled in the United States.
Emerald Health Therapeutics logo

Emerald Health Therapeutics

CVE:EMH
Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.